Japan has approved ground-breaking stem cell treatments for Parkinson’s and severe heart failure, one of the manufacturers and media reports said yesterday, with the therapies expected to reach patients within months.
Sumitomo Pharma said it received the green light for the manufacture and sale of Amchepry, its Parkinson’s disease treatment that transplants stem cells into a patient’s brain.
Japan’s Ministry of Health, Labor and Welfare also gave the go-ahead to ReHeart, heart muscle sheets developed by Cuorips that could help form new blood vessels and restore heart function, media reports said.
The treatments could be on the market and rolled out to patients as early as this summer, reports said, citing the health ministry, becoming the world’s first commercially available medical products using induced pluripotent stem (iPS) cells.
Japanese scientist Shinya Yamanaka won the Nobel Prize in 2012 for his research into iPS, which have the potential to develop into any cell in the body.
“I hope this will bring relief to patients not only in Japan but around the world,” Japanese Minister of Health, Labor and Welfare Kenichiro Ueno said. “We will promptly carry out all necessary procedures to ensure it reaches all patients without fail.”
In a statement, Sumitomo Pharma said it had obtained “conditional and time-limited approval” for the manufacture and marketing of Amchepry under a system which is reportedly designed to get these products to patients as quickly as possible.
The approval is a kind of “provisional license,” the Asahi Shimbun said, after the safety and efficacy of the treatment was judged based on data from fewer patients than in ordinary clinical trials for drugs.
A trial led by Kyoto University researchers indicated that the company’s treatment was safe and successful in improving symptoms.
The study involved seven Parkinson’s patients aged between 50 and 69, with each receiving a total of either 5 million or 10 million cells implanted on both sides of the brain. The iPS cells from healthy donors were developed into the precursors of dopamine-producing brain cells, which are no longer present in people with Parkinson’s disease.
The patients were monitored for two years and no major adverse effects were found, the study said.
Four patients showed improvements in symptoms.
Parkinson’s disease is a chronic, degenerative neurological disorder that affects the body’s motor system, often causing shaking and other difficulties in movement.
Worldwide, about 10 million people have the illness, the Parkinson’s Foundation said.
Currently available therapies “improve symptoms without slowing or halting the disease progression,” the foundation said.
An American scientist convicted of lying to US authorities about payments from China while he was at Harvard University has rebuilt his research lab in Shenzhen, China, to pursue technology the Chinese government has identified as a national priority: embedding electronics into the human brain. Charles Lieber, 67, is among the world’s leading researchers in brain-computer interfaces. The technology has shown promise in treating conditions such as amyotrophic lateral sclerosis and restoring movement in paralyzed people. It also has potential military applications: Scientists at the Chinese People’s Liberation Army have investigated brain interfaces as a way to engineer super soldiers by boosting
Jailed media entrepreneur Jimmy Lai (黎智英) has been awarded Deutsche Welle’s (DW) freedom of speech award for his contribution to Hong Kong’s pro-democracy movement. The German public broadcaster on Thursday said Lai would be presented in absentia with the 12th iteration of the award on June 23 at the DW Global Media Forum in Bonn. Deutsche Welle director-general Barbara Massing praised the 78-year-old founder of the now-shuttered news outlet Apple Daily for standing “unwaveringly for press freedom in Hong Kong at great personal risk.” “With Apple Daily, he gave journalists a platform for free reporting and a voice to the democracy movement in
PHILIPPINE COMMITTEE: The head of the committee that made the decision said: ‘If there is nothing to hide, there is no reason to hide, there is no reason to obstruct’ A Philippine congressional committee on Wednesday ruled that there was “probable cause” to impeach Philippine Vice President Sara Duterte after hearing allegations of unexplained wealth, misuse of state funds and threats to have the president assassinated. The unanimous decision of the 53-member committee in the Philippine House of Representatives sends the two impeachment complaints to deliberations and voting by the entire lower chamber, which has more than 300 lawmakers. The complaints centered on Duterte’s alleged illegal use and mishandling of intelligence funds from the vice president’s office, and from her time as education secretary under Philippine President Ferdinand Marcos Jr. Duterte and the
As evening falls in Fiji’s capital, a steady stream of people approaches a makeshift clinic that is a first line of defense against one of the world’s fastest-growing HIV epidemics. In the South Pacific nation — a popular tourist destination of just under a million people — more than 2,000 new HIV cases were recorded last year, a 26 percent increase from 2024. The government has declared an HIV outbreak and described it as a national crisis. “It’s spreading like wildfire,” said Siteri Dinawai, 46, who came to be tested. The Moonlight Clinic, a converted minibus parked in a suburban cul-de-sac in Suva, is
RSS